As a GLP-1 receptor agonist, semaglutide binds to GLP-1 receptors in the brain, particularly in areas controlling appetite such as the hypothalamus
It activates the GLP-1 receptor along with two others the GIP receptor and the glucagon receptor
Trusted Pharmacy Partnerships We exclusively use licensed compounding pharmacies that follow standards for safety and quality
We merge cutting-edge telehealth innovations with effective medications to provide a comprehensive service that includes doctor consultations, lab work, and unlimited supportall designed to make sustainable weight loss attainable
Everything is free: the drug, doctor visits, lab work, and monitoring
Orforglipron (LY3502970), a novel, oral nonpeptide glucagonlike peptide1 receptor agonist: a Phase 1a, blinded, placebocontrolled, randomized, singleand multipleascendingdose study in healthy participants